Canalis E, McCarthy T L, Centrella M
Department of Research, Saint Francis Hospital and Medical Center, Hartford, Connecticut 06105.
Endocrinology. 1991 Jul;129(1):534-41. doi: 10.1210/endo-129-1-534.
Insulin-like growth factor (IGF) I, a polypeptide synthesized by skeletal cells, and its amino terminus truncated derivative desamino-(1-3)-IGF I (des-IGF I) were compared for their effects on bone formation in vitro. Des-IGF I and IGF I were studied for their effects on DNA and collagen synthesis in cultures of intact fetal rat calvariae and of osteoblast-enriched (Ob) cells from fetal rat parietal bone, and for their ability to bind to IGF receptors in Ob cells and to IGF binding proteins (IGF-BPs) from calvariae. Des-IGF I and IGF I increased [3H] thymidine incorporation into DNA, [3H]proline incorporation into collagen and noncollagen protein, and the mitotic index in intact calvariae. Both factors had similar actions in calvariae. Des-IGF I stimulated all parameters studied at 1 nM, and IGF I was effective on the labeling of DNA at 1 nM, but concentrations of 10 nM were required to observe changes in collagen and noncollagen protein synthesis and in the mitotic index. The effect of des-IGF I on collagen synthesis was independent from that on DNA synthesis, as it is known for IGF I, and both forms of IGF I were equally potent for their inhibitory effects on collagen degradation in calvarial cultures. In Ob cells, neither des-IGF I nor IGF I altered the incorporation of [3H]thymidine into DNA, but both factors at 10-100 nM increased [3H]proline incorporation into collagen to a similar extent. Receptor studies revealed a similar binding capacity for des-IGF I and IGF I to the IGF I receptor(s) in Ob cells, although at 0.2 nM des-IGF I was slightly more effective than IGF I. In contrast, des-IGF I was 100-fold less effective than IGF I for its ability to bind to partially purified IGF-BPs from cultured calvariae. In conclusion, des-IGF I enhances calvarial DNA and collagen synthesis and osteoblastic collagen synthesis to a somewhat greater extent than IGF I, in spite of a much lesser affinity for IGF-BPs.
胰岛素样生长因子(IGF)I是一种由骨骼细胞合成的多肽,研究了其氨基末端截短的衍生物脱氨基-(1-3)-IGF I(des-IGF I)和IGF I对体外骨形成的影响。研究了des-IGF I和IGF I对完整胎鼠颅骨及胎鼠顶骨富含成骨细胞(Ob)的细胞培养物中DNA和胶原蛋白合成的影响,以及它们与Ob细胞中IGF受体和颅骨中IGF结合蛋白(IGF-BPs)结合的能力。des-IGF I和IGF I增加了[3H]胸苷掺入DNA、[3H]脯氨酸掺入胶原蛋白和非胶原蛋白以及完整颅骨中的有丝分裂指数。两种因子在颅骨中具有相似的作用。des-IGF I在1 nM时刺激了所有研究的参数,IGF I在1 nM时对DNA标记有效,但需要10 nM的浓度才能观察到胶原蛋白和非胶原蛋白合成以及有丝分裂指数的变化。des-IGF I对胶原蛋白合成的影响与对DNA合成的影响无关,这与IGF I的情况相同,两种形式的IGF I对颅骨培养物中胶原蛋白降解的抑制作用同样有效。在Ob细胞中,des-IGF I和IGF I均未改变[3H]胸苷掺入DNA,但10 - 100 nM的两种因子均使[3H]脯氨酸掺入胶原蛋白的程度相似。受体研究表明,des-IGF I和IGF I与Ob细胞中IGF I受体的结合能力相似,尽管在0.2 nM时des-IGF I比IGF I略有效。相比之下,des-IGF I与培养颅骨中部分纯化的IGF-BPs结合的能力比IGF I低100倍。总之,尽管des-IGF I对IGF-BPs的亲和力低得多,但它比IGF I更大程度地增强了颅骨DNA和胶原蛋白合成以及成骨细胞胶原蛋白合成。